相关实验视频
Updated: Sep 10, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
352
针对树突细胞特异性TNFR2改善皮肤和关节炎症
Raminderjit Kaur1,2, Jean Lin3, Jennifer E Harvey1
1Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, USA.
Scientific reports
|August 27, 2025
概括
在树突细胞 (DC) 中的瘤亡因子-α受体2 (TNFR2) 信号驱动着牛皮关节炎 (PsA) 的发展. 在DC中阻断TNFR2可降低类似PsA的炎症和促炎细胞因子的产生.
科学领域:
- 免疫学
- 皮肤病学
- 关节病学
背景情况:
- 牛皮和牛皮性关节炎是涉及TNF-α和树突细胞 (DC) 的炎症性疾病.
- 在DC介导的牛皮病发病过程中,TNF-α受体2 (TNFR2) 的确切作用尚不完全理解.
研究的目的:
- 在牛皮病期间调查TNFR2在树突细胞 (DC) 的功能.
- 确定DC中的TNFR2信号是否有助于牛皮关节炎 (PsA) 的发展.
主要方法:
- 使用曼寡糖 (MOS) 诱导的PsA小鼠模型.
- 患有完整TNFR2的小鼠与患有DC特异性TNFR2淘汰的小鼠的疾病严重程度比较 (DC-TNFR2KO).
- 评估了皮肤脱落,关节炎症,血清细胞因子和常规1型树突细胞 (cDC1) 种群.
主要成果:
- 在DC-TNFR2KO小鼠中,皮肤脱落和关节炎症显著减少.
- 在DC- TNFR2KO小鼠中抑制了cDC1种群的MOS诱导扩张.
- 在DC- TNFR2KO小鼠中,IL-12,TNF-α,IL-23和IL-17A的血清水平有所降低.
结论:
- 在树突细胞内TNFR2信号传递对于促进类似PsA的炎症至关重要.
- 针对DC- TNFR2途径为PsA和相关炎症症提供了潜在的治疗策略.
相关概念视频
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
230
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
230

